Terms: = Colorectal cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Clinical Outcome
7 results:
1. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract] [Full Text] [Related]
2. Loss of cdh1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.
Kim SA; Inamura K; Yamauchi M; Nishihara R; Mima K; Sukawa Y; Li T; Yasunari M; Morikawa T; Fitzgerald KC; Fuchs CS; Wu K; Chan AT; Zhang X; Ogino S; Qian ZR
Br J Cancer; 2016 Jan; 114(2):199-206. PubMed ID: 26742007
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract] [Full Text] [Related]
4. Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence.
Chen CH; Hsieh MC; Lai CC; Yeh CY; Chen JS; Hsieh PS; Chiang JM; Tsai WS; Tang R; Changchien CR; Wang JY
Int J Colorectal Dis; 2010 May; 25(5):567-71. PubMed ID: 20162425
[TBL] [Abstract] [Full Text] [Related]
5. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability.
Thorstensen L; Lind GE; Løvig T; Diep CB; Meling GI; Rognum TO; Lothe RA
Neoplasia; 2005 Feb; 7(2):99-108. PubMed ID: 15802015
[TBL] [Abstract] [Full Text] [Related]
6. Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.
Boxer G; Stuart-Smith S; Flynn A; Green A; Begent R
Br J Cancer; 1999 May; 80(5-6):922-6. PubMed ID: 10360677
[TBL] [Abstract] [Full Text] [Related]
7. The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome.
Rew DA; Karkera R; Mullee MA; Julious SA; Wilson GD
Eur J Surg Oncol; 1996 Oct; 22(5):508-15. PubMed ID: 8903495
[TBL] [Abstract] [Full Text] [Related]
